We are live on
!
Find out more
AH
Aviva Holdings Portfolio holdings
AUM
$20.5M
1-Year Est. Return
117.01%
This Fund
S&P 500
This Quarter
Est. Return
-10.5%
1 Year Est. Return
+117.01%
3 Year Est. Return
-36.54%
5 Year Est. Return
-22.08%
10 Year Est. Return
–
AUM
$13M
AUM Growth
-$143M
(-92%)
Cap. Flow
-$149M
Cap. Flow
% of AUM
-1,147.45%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
4
New
–
Increased
–
Reduced
1
Closed
2
Top Buys
No buys this quarter
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
MRTX
Mirati Therapeutics, Inc. Common Stock
MRTX
|
+$137M |
| 2 |
Inseego
INSG
|
+$2.29M |
| 3 |
Tango Therapeutics
TNGX
|
+$304K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 77.94% |
| 2 | Technology | 22.06% |
| 3 | Healthcare | 0% |
Similar funds
MFAM
SL
CIM
SFM
SFG
CGI
VFA
AMG
Aviva Holdings's Q4 2023 Portfolio in Review
As of Q4 2023, Aviva Holdings held 4 positions worth $13M, down 92% from $156M the previous quarter. Its ten largest holdings account for 100% of the portfolio.
Aviva Holdings withdrew a net $149M in Q4 2023, closing 2 positions and reducing 1 holding. Its most notable exit was Mirati Therapeutics, Inc. Common Stock, an estimated $137M position sold in full.
By sector, the portfolio is most concentrated in Miscellaneous at 78% of assets, up from 6.4% a quarter earlier, followed by Technology and Healthcare.
- Aviva Holdings's biggest Q4 2023 reduction was Inseego, cutting an estimated $2.29M.
- Aviva Holdings fully exited Mirati Therapeutics, Inc. Common Stock in Q4 2023, selling an estimated $137M.
- Aviva Holdings's ten largest holdings make up 100% of its $13M portfolio in Q4 2023.
- Aviva Holdings opened 0 new positions and closed 2 in Q4 2023.
- Aviva Holdings's portfolio value fell 92% quarter-over-quarter to $13M.
Based on Aviva Holdings's 13F filing for Q4 2023, filed 14 Feb 2024.